Terms: = Kidney tumors AND AKAP9, AKAP350, 10142, ENSG00000127914, KIAA0803, Q99996, AKAP450, YOTIAO, PRKA9, HYPERION, MU-RMS-40_16A, CG-NAP
6 results:
1. MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level.
Liu Y; Qi L; Ye B; Wang A; Lu J; Qu L; Luo P; Wang L; Jiang A
Cancer Biol Ther; 2024 Dec; 25(1):2345977. PubMed ID: 38659199
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.
Li Y; Chyan MK; Hamlin DK; Nguyen H; Vessella R; Wilbur DS
Nucl Med Biol; 2021 Jan; 92():217-227. PubMed ID: 32409263
[TBL] [Abstract] [Full Text] [Related]
3. Tumour heterogeneity in triplet-paired metastatic tumour tissues in metastatic renal cell carcinoma: concordance analysis of target gene sequencing data.
Kim SH; Park WS; Chung J
J Clin Pathol; 2019 Feb; 72(2):152-156. PubMed ID: 30409839
[TBL] [Abstract] [Full Text] [Related]
4. [Radical antegrade modular pancreatosplenectomy procedure in pancreatic body/tail adenocarcinoma].
Cao F; Oba T; Saiura P; Li F
Zhonghua Wai Ke Za Zhi; 2016 Nov; 54(11):833-838. PubMed ID: 27806776
[TBL] [Abstract] [Full Text] [Related]
5. Can particle beam therapy be improved using helium ions? - a planning study focusing on pediatric patients.
Knäusl B; Fuchs H; Dieckmann K; Georg D
Acta Oncol; 2016 Jun; 55(6):751-9. PubMed ID: 26750803
[TBL] [Abstract] [Full Text] [Related]
6. On the performances of different IMRT Treatment Planning Systems for selected paediatric cases.
Fogliata A; Nicolini G; Alber M; Asell M; Clivio A; Dobler B; Larsson M; Lohr F; Lorenz F; Muzik J; Polednik M; Vanetti E; Wolff D; Wyttenbach R; Cozzi L
Radiat Oncol; 2007 Feb; 2():7. PubMed ID: 17302972
[TBL] [Abstract] [Full Text] [Related]
